Demo Sign up Log In

AstraZeneca PLC Ordinary Shares (AZN)

Operating Expenses

$9.70B

Quarterly · Period ending: Jun 30, 2026 · USD

AZN Operating Expenses

Latest reported$9.70Bperiod endingJun 30, 2026

Latest reported$9.70Bperiod endingJun 30, 2026

AZN Quarterly Operating Expenses ($1.75B → $9.70B)

Quarterly operating expenses

High-resolution chart · PNG

AZN operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Operating Expenses — Quarterly (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	2,047,000,000
Mar 31, 2001	1,880,885,753
Dec 31, 2000	5,597,865,970
Sep 30, 2000	1,900,845,201
Jun 30, 2000	1,987,989,537
Mar 31, 2000	1,924,517,533
Dec 31, 1999	5,366,244,402
Sep 30, 1999	2,118,000,000
Jun 30, 1999	2,305,000,000
Mar 31, 1999	4,521,500,000
Dec 31, 1998	1,887,387,218
Sep 30, 1998	2,330,200,000
Jun 30, 1998	1,680,000,000
Mar 31, 1998	2,417,500,000
Dec 31, 1997	2,288,059,340
Sep 30, 1997	2,099,400,000
Jun 30, 1997	2,284,000,000
Mar 31, 1997	2,284,000,000
Dec 31, 1996	4,557,062,756
Sep 30, 1996	2,313,600,000
Jun 30, 1996	2,278,500,000
Mar 31, 1996	2,278,500,000
Dec 31, 1995	1,763,552,932
Sep 30, 1995	1,935,000,000
Jun 30, 1995	690,400,000
Mar 31, 1995	2,017,100,000
Dec 31, 1994	1,826,649,215
Sep 30, 1994	1,752,800,000
Jun 30, 1994	1,836,800,000
Mar 31, 1994	1,836,800,000
Dec 31, 1993	1,533,658,718
Sep 30, 1993	1,537,000,000
Jun 30, 1993	1,748,500,000
Mar 31, 1993	1,748,500,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.